Cerebellar ataxias
暂无分享,去创建一个
[1] F. Gabreëls,et al. Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. , 2000, Brain : a journal of neurology.
[2] M. Zeviani. The expanding spectrum of nuclear gene mutations in mitochondrial disorders. , 2001, Seminars in cell & developmental biology.
[3] S. Perlman. Ataxias , 2002, Journal of the Neurological Sciences.
[4] T. Ebner,et al. Hereditary cerebellar ataxia progressively impairs force adaptation during goal-directed arm movements. , 2004, Journal of neurophysiology.
[5] Y. Agid,et al. Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients. , 2004, Brain : a journal of neurology.
[6] H. Waterham,et al. Molecular basis of Refsum disease: Sequence variations in Phytanoyl‐CoA Hydroxylase (PHYH) and the PTS2 receptor (PEX7) , 2004, Human mutation.
[7] L. Peltonen,et al. Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky. , 2005, Human molecular genetics.
[8] I. Harting,et al. Mutations in SIL1 cause Marinesco-Sjögren syndrome, a cerebellar ataxia with cataract and myopathy , 2005, Nature Genetics.
[9] J. Lupski,et al. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1 , 2005, Nature.
[10] K. Vlahovicek,et al. Molecular analysis of the HEXA gene in Italian patients with infantile and late Onset Tay‐Sachs disease: detection of fourteen novel alleles , 2005, Human mutation.
[11] Y. Liou,et al. Brain-specific BNIP-2-homology protein Caytaxin relocalises glutaminase to neurite terminals and reduces glutamate levels , 2006, Journal of Cell Science.
[12] L. Kaczmarek,et al. Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia , 2006, Neurogenetics.
[13] M. Zeviani,et al. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. , 2006, Brain : a journal of neurology.
[14] T. Ebner,et al. Force field effects on cerebellar Purkinje cell discharge with implications for internal models , 2006, Nature Neuroscience.
[15] Masao Ito. Cerebellar circuitry as a neuronal machine , 2006, Progress in Neurobiology.
[16] K. Caldecott,et al. TDP1-dependent DNA single-strand break repair and neurodegeneration. , 2006, Mutagenesis.
[17] S. Perlman,et al. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia , 2006, Nature chemical biology.
[18] C. Espinós,et al. Orphanet Journal of Rare Diseases BioMed Central Review , 2006 .
[19] U Walter,et al. Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17). , 2006, Brain : a journal of neurology.
[20] N. Ramnani. The primate cortico-cerebellar system: anatomy and function , 2006, Nature Reviews Neuroscience.
[21] M. Mori,et al. Intravenous immunoglobulin therapy for Miller Fisher syndrome , 2007, Neurology.
[22] S. Rivera,et al. Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS) , 2007, Neurology.
[23] S. Nelson,et al. A new episodic ataxia syndrome with linkage to chromosome 19q13. , 2007, Archives of neurology.
[24] A. Munnich,et al. Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. , 2007, The Journal of clinical investigation.
[25] J. Brunberg,et al. Fragile X‐associated tremor/ataxia syndrome: Clinical features, genetics, and testing guidelines , 2007, Movement disorders : official journal of the Movement Disorder Society.
[26] J. V. van Swieten,et al. Diagnosis and management of early‐ and late‐onset cerebellar ataxia , 2006, Clinical genetics.
[27] D. Marmolino,et al. Friedreich’s Ataxia: From the (GAA)n Repeat Mediated Silencing to New Promising Molecules for Therapy , 2009, The Cerebellum.
[28] J. Jen. Hereditary Episodic Ataxias , 2008, Annals of the New York Academy of Sciences.
[29] E. Tournier-Lasserve,et al. Large CACNA 1 A Deletion in a Family With Episodic Ataxia Type 2 , 2008 .
[30] Osamu Onodera,et al. Sporadic ataxias in Japan – a population-based epidemiological study , 2008, The Cerebellum.
[31] V. Cheung,et al. ATM gene mutations result in both recessive and dominant expression phenotypes of genes and microRNAs. , 2008, American journal of human genetics.
[32] J. Cruysberg,et al. ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia , 2008, neurogenetics.
[33] Caterina Tonon,et al. Idebenone in Friedreich's ataxia. , 2008, Expert opinion on pharmacotherapy.
[34] Andreas R. Luft,et al. Magnetic resonance imaging in spinocerebellar ataxias , 2008, The Cerebellum.
[35] A. Bastian,et al. Cerebellum and the deciphering of motor coding , 2007, The Cerebellum.
[36] K. Devriendt,et al. A novel genomic disorder: a deletion of the SACS gene leading to Spastic Ataxia of Charlevoix–Saguenay , 2008, European Journal of Human Genetics.
[37] L. Tranebjaerg,et al. Novel SIL1 mutations and exclusion of functional candidate genes in Marinesco–Sjögren syndrome , 2008, European Journal of Human Genetics.
[38] D. Rubinsztein,et al. Spinocerebellar ataxias caused by polyglutamine expansions: A review of therapeutic strategies , 2008, The Cerebellum.
[39] A. Monticelli,et al. Recombinant Human Erythropoietin Increases Frataxin Protein Expression Without Increasing mRNA Expression , 2008, The Cerebellum.